MapLight Therapeutics MPLT
NASDAQ MPLT
$7.59 +0.15 (+2.02%)
As of: Nov 11, 2026 · 2:59 PM EST

MapLight Therapeutics (MPLT) Income After Tax (2024 - 2026)

Updated

MapLight Therapeutics' Income After Tax came in at -$61.2 million for Q2 2026, compared with -$29.98 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Income After Tax (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, MapLight Therapeutics reported Income After Tax of -$202.03 million; for FY2025, it came in at -$163.57 million.

  • Going back by year, Income After Tax was -$78.44 million in FY2024.
  • The five-year range for quarterly Income After Tax is -$80.91 million (Q4 2025) to -$19.81 million (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.80 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - -61.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -61.20 Mn
Mar 31, 2026 -62.03 Mn
Dec 31, 2025 -80.91 Mn
Sep 30, 2025 -29.95 Mn
Jun 30, 2025 -29.98 Mn
Mar 31, 2025 -22.73 Mn
Dec 31, 2024 -21.88 Mn
Sep 30, 2024 -19.81 Mn
API Access

MapLight Therapeutics Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MPLT&period=max&api_key=YOUR_API_KEY